Persistence, Compliance And Bisphosphonate Switching In Patients With Multiple Myeloma (MM) In Germany

OBJECTIVES: This retrospective observational analysis aimed to estimate persistence, compliance and switch patterns in MM patients newly treated with bispho-sphonates (BPs) approved in Germany for the prevention of SREs. METHODS: This was a retrospective analysis of German health insurance claims data (including ~4 million patients). The study included newly diagnosed MM patients aged ≥18 with no prior hypercalcemia, undergoing BP treatment for the first time. Descriptive analyses to estimate persistence, compliance and switch rate among first line intravenous BP treatments were performed. Persistence was defined as continuous prescriptions with